<DOC>
	<DOCNO>NCT00330785</DOCNO>
	<brief_summary>To evaluate effectiveness amlodipine/atorvastatin therapy assess percentage subject reach target blood pressure ( BP ) LDL-C target define govern guideline .</brief_summary>
	<brief_title>Open Label Study Assessing Effectiveness Of Amlodipine/Atorvastatin In Subjects With Hypertension Dyslipidaemia</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Dyslipidemias</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<mesh_term>Amlodipine , atorvastatin drug combination</mesh_term>
	<mesh_term>Amlodipine</mesh_term>
	<criteria>Patients target LDLC BP eligible treatment High liver enzyme</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>April 2007</verification_date>
</DOC>